Does low magnesium constrain B-vitamin activation and homocysteine handling?

Magnesium plays a fundamental, underappreciated role in regulating one-carbon metabolism, genomic stability, and cardiovascular health through its essential cofactor activities.

Mechanistic pathways of B-vitamin activation

• Enzymatic phosphorylation: Pyridoxal kinase (PDXK), the enzyme that converts inactive dietary vitamin B6 into its active coenzyme form, pyridoxal-5-phosphate (PLP), requires both free $\text{Mg}^{2+}$ and $\text{MgATP}$ as physiological substrates. Low magnesium directly restricts PDXK catalytic activity.
• Cellular uptake: Utilization of active PLP relies on tissue uptake mediated by alkaline phosphatase, a magnesium-dependent metalloenzyme. Magnesium deficiency inhibits this process, reducing systemic PLP availability.
• Methyl donor synthesis: Magnesium is a mandatory cofactor for methionine adenosyltransferase (MAT), the enzyme responsible for synthesizing S-adenosylmethionine (SAM)—the primary universal methyl donor for DNA and protein methylation.

Impact on homocysteine and methylation

• Impaired transsulfuration: Deficient B6 activation directly compromises the activity of cystathionine $\beta$-synthase (CBS), a PLP-dependent enzyme. This impairs the transsulfuration pathway, triggering homocysteine accumulation (hyperhomocysteinemia) independently of folate or vitamin B12 levels.
• DNA integrity: The combination of restricted SAM synthesis and elevated homocysteine levels due to low magnesium availability restricts global methylation flow, which is strongly linked to heightened chromosomal and DNA damage.

Bottom line

• Magnesium deficiency acts as a major metabolic bottleneck by impairing the ATP-dependent activation of vitamin B6 and the synthesis of SAM, ultimately restricting methylation flow and compromising homocysteine clearance.